Global Health (Medanta) MEDANTA
High-acuity super-specialty hospitals under the Medanta brand - Gurugram flagship plus Lucknow, Patna, Indore, Ranchi and a new Noida hospital
Mapped in 1 theme: Hospitals & Healthcare.
Where Global Health (Medanta) sits in the supply chain
Global Health (Medanta) appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Multi-specialty hospital chains
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 2,167 | 2,710 | 3,275 | 3,692 | 4,410 |
| Net profit | 196 | 326 | 478 | 481 | 554 |
Latest-year revenue ₹4,410 Cr (FY26, company-wide).
Strengths
- Clinical reputation in transplants, cardiac and neuro sciences drives high ARPOB
- Lucknow and Patna show the model works in under-served state capitals
- Strong balance sheet funding the next wave of hospitals
Risks
- Gurugram flagship still a large share of profit
- New Noida and pipeline hospitals weigh on margins while they ramp up
- Doctor-led brand: retaining senior clinicians is critical
Common questions
What does Global Health (Medanta) do?
High-acuity super-specialty hospitals under the Medanta brand - Gurugram flagship plus Lucknow, Patna, Indore, Ranchi and a new Noida hospital.
Where does Global Health (Medanta) sit in the supply chain?
Global Health (Medanta) (NSE: MEDANTA) is mapped in 1 supply-chain layer: Multi-specialty hospital chains (Hospitals & Healthcare).
Who are Global Health (Medanta)'s peers?
In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises (Manipal Hospitals), Fortis Healthcare, Narayana Hrudayalaya (Narayana Health), Aster DM Quality Care and 5 more.
What is Global Health (Medanta)'s market cap and valuation?
As of 6 Nov 2026: market cap ₹37,296 Cr, P/E 57.6x, ROCE 17.4%, ROE 15.2%, dividend yield 0.04%.